ArticleJournal of breast cancer2021

Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability.

Soomin Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.